Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Syzygium aromaticum Phytoconstituents Target SARS-CoV-2: Integrating Molecular Docking, Dynamics, Pharmacokinetics, and miR-21 rs1292037 Genotyping

5 Jul 2025

Abstract excerpt

Background and aim: The COVID-19 pandemic, caused by SARS-CoV-2, remains a global health crisis despite vaccination efforts, necessitating novel therapeutic strategies. Natural compounds from Syzygium aromaticum (clove), such as eugenol and β-caryophyllene, exhibit antiviral and anti-inflammatory properties, while host genetic factors, including miR-21 rs1292037 polymorphism, may influence disease susceptibility...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to Pharmacological Receptor Mechanisms and Effects

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to SARS-CoV-2 and COVID-19 Research

Source

Identifiers

PMID: 40733568
DOI: 10.3390/v17070951

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 12 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Syzygium aromaticum Phytoconstituents Target SARS-CoV-2: Integrating Molecular Docking, Dynamics, Pharmacokinetics, and miR-21 rs1292037 GenotypingPMID 40733568Read ↗

The Pan-African Natural Products Library Compounds Oleanolic Acid, Poinsettifolin B, and Rhuschalcone III Disrupt SARS-CoV-2 Spike-Host ACE2 Interactions and SARS-CoV-2 ReplicationSemantic proximity Read ↗

Discovery of Potential Inhibitors of the Receptor-binding Domain (RBD) of Pandemic Disease-causing SARS-CoV-2 Spike Glycoprotein from Triphala Through Molecular DockingSemantic proximity Read ↗

Annual SZ® A Novel Formulation For COVID-19 Therapy Clinical Trial StudiesSemantic proximity Read ↗

Network pharmacology, molecular docking, and dynamics analyses to predict the antiviral activityof ginger constituents against coronavirus infectionSemantic proximity Read ↗

In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targetsSemantic proximity Read ↗

Therapeutic Role of Phytophenol Gallic Acid for the Cure of COVID-19 Pathogenesis.Semantic proximity Read ↗

Daucosterol and Beta-Sitosterol – the Future-Ready phytochemicals from Terminalia chebula to combat SARS-CoV-2Semantic proximity Read ↗

Inhibition potential of natural flavonoids against selected omicron (B.1.19) mutations in the spike receptor binding domain of SARS-CoV-2: a molecular modeling approach.Semantic proximity Read ↗

In Silico Study of Coumarins: Wedelolactone as a Potential Inhibitor of the Spike Protein of the SARS-CoV-2 VariantsSemantic proximity Read ↗

The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2 in vitroSemantic proximity Read ↗

A study on the effect of natural products against the transmission of B.1.1.529 OmicronSemantic proximity Read ↗

Corilagin and 1,3,6-Tri-O-galloy-β-D-glucose: potential inhibitors of SARS-CoV-2 variants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.